Cargando…
Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling
This study aimed to investigate the effects of Ginsenoside Rh4 (Rh4) on inflammation-related hepatocellular carcinoma (HCC) progression and the underlying mechanism. HCC cells (HUH7 and LM3) were induced by lipopolysaccharide (LPS) to establish an inflammatory environment in the absence or presence...
Autores principales: | Jiang, Ruiyuan, Luo, Shujuan, Zhang, Meng, Wang, Wei, Zhuo, Shaoyuan, Wu, Yajing, Qiu, Qingmei, Yuan, Yuan, Jiang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657317/ https://www.ncbi.nlm.nih.gov/pubmed/37843550 http://dx.doi.org/10.1007/s00438-023-02070-w |
Ejemplares similares
-
Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling
por: Zhang, Yan, et al.
Publicado: (2022) -
The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
por: Lin, Yingjia, et al.
Publicado: (2017) -
Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy
por: Yang, Zhiqing, et al.
Publicado: (2016) -
Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation
por: Mathiyalagan, Ramya, et al.
Publicado: (2019) -
(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2021)